RedHill Biopharma Announces $6M Private Placement From OrbiMed Israel Partners Limited Partnership

Charles Gross , Benzinga Staff Writer

December 30, 2013 6:46am Comments

RedHill Biopharma (Nasdaq: RDHL) today announced that it has entered into a definitive agreement with leading healthcare investor OrbiMed Israel Partners Limited Partnership, an affiliate of OrbiMed Advisors LLC, for the sale of RedHill's American Depository Shares and warrants in a private placement transactionor a total sum of $6.0 million.

See full press release

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: News Guidance Financing Offerings Contracts Management Global

1	AMC, BB: Cramer Calls Wednesday's GameStop Surge 'A Mockery'
2	TCOM, PFIE: 48 Stocks Moving in Tuesday's Pre-Market Session
3	LGHL, SLRX: 48 Stocks Moving in Wednesday's Pre-Market Session
4	VWAGY, TSLA: 9 Key Takeaways From The Lucid Motors SPAC...
5	TSLA, MSFT: Bill Gates On Investing In Bitco...
6	SQ, NVDA: Square And Nvidia – Ea...
7	THCB, RIDE: Oshkosh Nabs U...

1	PCRFY, GM: US Needs To Make Batteries On A Large-Scale To Avoid Chip-Like Shortage...
2	Fintech Focus For February 25, 2021
3	BB, GME: Cramer Calls Wednesday's GameStop Surge 'A Mockery'
4	GME: Fintech Spotlight: OVTLYR Launches Behavioral Analytics Tool...
5	DM, MSFT: Additive Manufacturing Leader Markforged Gets SPAC De...
6	AAPL: 6 Key Questions Apple Answered At The Annual Shar...
7	TSLA, $BTC: Tesla's Swoon: Is Bitcoin The Tail...

+

+

Market Overview

Tickers

Articles

Keywords

RedHill Biopharma Announces $6M Private Placement From OrbiMed Israel Partners Limited Partnership

Related Articles (RDHL)